207 related articles for article (PubMed ID: 16323973)
41. Oral vasoactive medication in intermittent claudication: utile or futile?
De Backer TL; Vander Stichele RH; Warie HH; Bogaert MG
Eur J Clin Pharmacol; 2000 Jun; 56(3):199-206. PubMed ID: 10952473
[TBL] [Abstract][Full Text] [Related]
42. Cilostazol.
Sorkin EM; Markham A
Drugs Aging; 1999 Jan; 14(1):63-71; discussion 72-3. PubMed ID: 10069409
[TBL] [Abstract][Full Text] [Related]
43. Can claudication be improved with medication?
Conners MS; Money SR
Semin Vasc Surg; 2002 Dec; 15(4):237-44. PubMed ID: 12478498
[TBL] [Abstract][Full Text] [Related]
44. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies.
Momsen AH; Jensen MB; Norager CB; Madsen MR; Vestersgaard-Andersen T; Lindholt JS
Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):463-74. PubMed ID: 19586783
[TBL] [Abstract][Full Text] [Related]
45. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
Peters H; Kieser M; Hölscher U
Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
[TBL] [Abstract][Full Text] [Related]
46. Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study.
Diehm C; Kühn A; Strauss R; Hübsch-Müller C; Kübler W
Vasa Suppl; 1989; 28():26-30. PubMed ID: 2609241
[TBL] [Abstract][Full Text] [Related]
47. Intravenous naftidrofuryl for critical limb ischaemia.
Smith FB; Bradbury A; Fowkes G
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD002070. PubMed ID: 22786478
[TBL] [Abstract][Full Text] [Related]
48. A randomized trial of iloprost in patients with intermittent claudication.
Creager MA; Pande RL; Hiatt WR
Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
[TBL] [Abstract][Full Text] [Related]
49. Naftidrofuryl (Praxilene) in peripheral vascular disease.
Drug Ther Bull; 1979 Oct; 17(21):83-4. PubMed ID: 498948
[No Abstract] [Full Text] [Related]
50. [Evidence-based therapy of intermittent claudication].
Krankenpfl J; 2004; 42(5-6):184. PubMed ID: 15527244
[No Abstract] [Full Text] [Related]
51. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
52. Ginkgo biloba for intermittent claudication.
Nicolaï SP; Kruidenier LM; Bendermacher BL; Prins MH; Teijink JA
Cochrane Database Syst Rev; 2009 Apr; (2):CD006888. PubMed ID: 19370657
[TBL] [Abstract][Full Text] [Related]
53. Placebo-controlled, double-blind, two-centre trial of ketanserin in intermittent claudication.
Bounameaux H; Holditch T; Hellemans H; Berent A; Verhaeghe R
Lancet; 1985 Dec; 2(8467):1268-71. PubMed ID: 2866336
[TBL] [Abstract][Full Text] [Related]
54. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
Trübestein G; Böhme H; Heidrich H; Heinrich F; Hirche H; Maass U; Mörl H; Rudofsky G
Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
[TBL] [Abstract][Full Text] [Related]
55. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
Mangiafico RA; Messina R; Attinà T; Dell'Arte S; Giuliano L; Malatino LS
Angiology; 2000 Jun; 51(6):441-9. PubMed ID: 10870853
[TBL] [Abstract][Full Text] [Related]
56. Prostanoids in the treatment of intermittent claudication--a meta-analysis.
Reiter M; Bucek RA; Stümpflen A; Dirisamer A; Minar E
Vasa; 2002 Nov; 31(4):219-24. PubMed ID: 12510544
[TBL] [Abstract][Full Text] [Related]
57. Treatment of intermittent claudication: cilostazol.
Collins P; Brittenden J
Hosp Med; 2004 Aug; 65(8):466-70. PubMed ID: 15330347
[TBL] [Abstract][Full Text] [Related]
58. Effect of intravenous naftidrofuryl on transcutaneous oxygen pressure in severe peripheral vascular disease.
Taggart I; Wishart GC; Cuschieri RJ; MacBain GC
Angiology; 1989 Oct; 40(10):895-8. PubMed ID: 2802260
[TBL] [Abstract][Full Text] [Related]
59. A statistical consideration of CLAU-S: a disease specific questionnaire for the assessment of quality of life in patients with intermittent claudication.
Spengel FA; Lehert P; Dietze S
Vasa; 1998 Nov; 27(4):253. PubMed ID: 9859750
[No Abstract] [Full Text] [Related]
60. Naftidrofuryl in the treatment of vascular dementia.
Möller HJ; Hartmann A; Kessler C; Rainer M; Brown T; Gamand S; Lehert P
Eur Arch Psychiatry Clin Neurosci; 2001 Dec; 251(6):247-54. PubMed ID: 11881837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
